Prognostic Value of Each Codon-specific KRAS Mutation in Col... | Clinical Trial | StuddyBuddy@endsection Prognostic Value of Each Codon-specific KRAS Mutation in Colorectal Cancer
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05657210

Prognostic Value of Each Codon-specific KRAS Mutation in Colorectal Cancer

Conditions: Colorectal Cancer

Sex: All
Enrollment: 2203
Sponsor: Seoul National University Bundang Hospital

Location: Korea, Republic of

Summary

This retrospective study reviewed 3,144 patients who underwent surgery for colorectal cancer. This study was designed to comprehend the clinicopathological characteristics associated with individual codon-specific KRAS mutations in colorectal cancer.

Eligibility Criteria

Inclusion Criteria:Patients underwent surgery for colorectal cancer from January 2009 to December 2019.Exclusion Criteria:incomplete data on KRAS mutationincomplete data on microsatellite instability (MSI) statusdual or triple KRAS mutationstage IV

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05657210). StuddyBuddy aggregates publicly available trial information.